Rehab program shows promise for long COVID sufferers with chronic illness

NCT ID NCT06871293

First seen Apr 20, 2026 · Last updated Jun 19, 2026 · Updated 9 times

Summary

This study tests whether an 8-week program of supervised physical and cognitive exercises can improve walking, thinking, strength, and quality of life in 374 adults with Long COVID and conditions like high blood pressure or diabetes. Participants are randomly assigned to either the rehab program or to receive weekly health tips. Researchers will check progress right after the program and again six months later.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fundación Cardioinfantil-Instituto de cardiología

    RECRUITING

    Bogotá, Bogotá DC, 110131, Colombia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

functional and cognitive rehabilitation program

What this could lead to

If it works, this could point toward a practical, non-drug therapy to help people with Long COVID and chronic diseases move better, think clearer, and feel better day-to-day.

What could go wrong

This is a relatively small, early-stage study (374 people) comparing rehab to simple health messages. The results may not apply to everyone, and the program requires weekly in-person visits for 8 weeks, which may be hard for some to maintain.

Conditions

The condition(s) this trial relates to.

COVID-19 diabetes mellitus hypertensive disorder long COVID-19 Noncommunicable Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.